News

JENIN, April 9, 2025 (WAFA) – Israeli occupation forces Wednesday demolished several Palestinian homes in Jenin refugee camp, according to WAFA correspondent. He said that Israeli bulldozers ...
GUBamy, the amylin obe­si­ty can­di­date de­vel­oped by Gubra and li­censed to Ab­b­Vie for $350 mil­lion last month, demon­strat­ed en­cour­ag­ing weight loss in … ...
CagriSema is a combination of cagrilintide — a nascent form of weight loss treatment known as an amylin analog — and semaglutide, the active ingredient in Wegovy. Headline results from a ...
CagriSema, which the pharma had been positioning as the successor to its Ozempic and Wegovy, combines semaglutide with cagrilintide, a peptide mimic of the pancreatic hormone amylin. Many analysts and ...
This partnership will leverage Iktos’s AI platform and Cube Biotech’s advanced protein technologies to develop novel agonists of the Amylin Receptor. Insilico Medicine is intent on using AI for every ...
NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic ...
The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders.
Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), insulin resistance, and a decrease in insulin production. For some people, type 2 diabetes can be managed with ...
Rwanda should be next in line.” @hjmaluks wrote: “Coach Hugo Bross is cooking stru Bafana Bafana winning away Games with Easy…that’s priceless.” “I see Summer Walker. I need to see ...
Mangrove's P&C solutions are tailored to Florida's unique market. Insurance and reinsurance executive Stephen Weinstein is founder and CEO of Mangrove Property Insurance. New Hires Demonstrate ...